Skip to main content
mSphere logoLink to mSphere
. 2026 Feb 25;11(3):e00770-25. doi: 10.1128/msphere.00770-25

The utility of fibroblast co-culture for the maintenance of episomes in human papillomavirus-associated cancer models

Austin J Witt 1, Rachel L Lewis 1, Xu Wang 1, Phoebe Bridy 1, Jenny Roe 1, Iain M Morgan 1,2, Claire D James 1,2, Molly L Bristol 1,2,✉
Editor: Ira J Blader3
PMCID: PMC13037401  PMID: 41738763

ABSTRACT

Human papillomavirus-associated head and neck squamous cell carcinomas (HPV+ HNSCCs) lack early diagnostics and continue to rise in incidence. HPV16 has been detected in ~90% of HPV+ oropharyngeal cancers (HPV+ OPCs), an anatomical subset of HNSCC, with the majority retaining episomal viral genomes. Despite this, existing episomal HPV16+ OPC cell lines are especially scarce. UMSCC104s were initially reported as episomal; however, the literature contains conflicting reports regarding the genome status of these cells. We now show that UMSCC104s rapidly undergo integration and E2 loss under standard monoculture, and later lots are fully integrated. These findings resolve prior discrepancies and underscore the instability of episomes in monoculture. Accurate models of HPV-driven cancers are critically needed. We propose fibroblast co-culture methods, traditionally utilized for HPV+ keratinocyte models, as a strategy to preserve episomal status in cancer models by supporting viral and host genome stability.

KEYWORDS: fibroblasts, HPV, oropharyngeal cancer, HNSCC, co-culture

INTRODUCTION

Human papillomaviruses (HPVs) are oncogenic viruses responsible for approximately 5% of human cancers, including a growing subset of head and neck squamous cell carcinomas (HNSCCs) (1–3). Among these, HPV+ oropharyngeal cancers (HPV+ OPCs) have risen sharply in incidence, with HPV16 detected in as high as 90% of cases (3, 4). While HPV+ OPC patients generally have favorable prognoses, the substantial long-term morbidities among survivors highlight the urgent need for improved therapeutic approaches (4–6). To this point, there is a significant need for appropriate preclinical models to study this disease.

HPV episomal genome status is prognostically significant in HNSCC, and more than 70% of HPV+ OPC patient tumors retain extrachromosomal viral episomes (6–9). Episomal status is associated with significantly improved overall survival, when compared to tumors with integrated genomes or HPV-negative disease (6). Conversely, most existing HPV16+ HNSCC cell lines are derived from non-oropharyngeal sites and contain integrated viral genomes, thus limiting their clinical relevance (3, 6–11). The successful establishment of HNSCC cell lines has been shown to correlate with poor prognosis for the associated patients (9, 12). This may partially account for the selective availability of cell lines harboring integrated viral genomes, as they have poor prognostics and in turn may be more likely to yield stable cell lines than those retaining episomal HPV. We also suggest that the traditional monoculture approach commonly utilized for cancer cells may likewise hinder the establishment of episomal lines, consistent with knowledge that fibroblast co-culture is essential for episomal maintenance in other epithelial models (13). This idea is further supported by our recent observation that 50% of a set of HPV16+ OPC patient-derived xenografts (PDXs) retain episomal genomes, potentially due to their consistent maintenance adjacent to mouse stroma (3).

Upon initial HPV infection, viral genomes are maintained as low-copy extrachromosomal episomes in basal keratinocytes (13). In vivo, infected basal keratinocytes are adjacent to the stroma, and fibroblasts are a major component in this microenvironment (14). Fibroblasts are noted to secrete essential growth factors that regulate both keratinocyte proliferation and differentiation (10, 13). In vitro, episomes are generally unstable unless HPV+ keratinocyte cell lines are established and maintained in a co-culture system utilizing inactivated 3T3-J2 murine fibroblasts (J2s) (10, 13, 14). It is well established that without J2s, HPV+ keratinocyte cultures rapidly integrate the viral genome; previously, we have observed significant HPV16 integration in N/Tert-1 and human foreskin keratinocyte cell lines within one week of fibroblast removal (10, 13). Of note, cervical intraepithelial neoplasia (CIN) episomal cell lines, such as W12 (HPV16) and CIN612-9E (HPV31), were also established using fibroblast co-culture conditions (15). As feeder-layer fibroblasts are vital for establishing and maintaining episomal keratinocyte and CIN models, we further suggest that J2 co-culture methods should be adapted and utilized for the establishment and maintenance of episomes in clinically relevant HPV-associated cancer models (9, 10).

RESULTS

Rapid episome loss in UMSCC104s when grown in traditional monoculture

Only a limited number of HPV+ HNSCC cell lines are commercially available, with most harboring integrated viral genomes; this does not reflect the clinical abundance of episomal HPV+ OPC (6, 7, 9). UMSCC104s (HPV16+ HNSCC cell line) were originally reported to contain episomal HPV16 genomes (16). Of note, there is significant disagreement in the literature as to the episomal status of these cells (11, 16, 17). We investigated whether this may be due to integration of the viral genome during passaging. Passage 3 UMSCC104 cells, from a lot originally obtained in 2015, demonstrate the presence of episomal DNA via Southern blotting (Fig. 1A; for methodology see reference 18). These were compared against UMSCC47 and UMSCC152 cells, containing known integration sites, as well as HPV-negative HN4 cells (11, 17, 19). The ExoV exonuclease assay provides a more sensitive and quantitative method for detecting HPV16 episomes and genome integration events, offering distinct advantages over Southern blotting for tracking integration dynamics (3, 19). Using the ExoV exonuclease assay, we observed that viral genome integration occurs rapidly during passaging of UMSCC104 (Fig. 1B, for methodology see references) (3, 19). Within 25 passages, UMSCC104 viral genome status transitioned from primarily episomal to fully integrated, and both E2 and E6 viral DNA presence was significantly reduced (Fig. 1B); of note, E2 and E6 DNA levels remained detectable over background. Moreover, UMSCC104 lots obtained in 2024 were fully integrated upon receipt when measured by ExoV (Fig. 1C), underscoring the inherent instability of episomes under basic vendor monoculture maintenance and expansion protocols prior to distribution. Importantly, these measurements reflect viral DNA abundance at a single time point and do not capture transcriptional output. Prior work from our group has demonstrated that HPV transcriptional output can be strongly influenced by cellular stress and microenvironmental context (10). We further speculate on this point in the discussion.

Fig 1.

Analysis of HPV episomal instability in UMSCC104 cells across passages. Southern blots and ExoV assays demonstrate increasing HPV16 genome integration over time. Western blots show E2 protein expression changes with J2 treatment versus standard culture.

HPV episomal instability of UMSCC104 cells grown with traditional monoculture methods. (A) Total cellular DNA was extracted from HN4, UMSCC47, UMSCC104, and UMSCC152 cell lines. Five micrograms of DNA was digested with either SphI (to linearize the HPV16 genome) or HindIII (which fails to cut the HPV16 genome). Membranes were probed with radiolabeled (32-P) HPV16 genome and then visualized by exposure to film. The image presented was after 1-h exposure. (B) Early passage UMSCC104s, obtained from Millipore in 2015, were serially passaged and analyzed via the ExoV exonuclease assay at noted passage numbers (x-axis). Percent integration was calculated from the ratio of circular and linear E2 viral DNA in comparison to host mitochondrial (circular) and GAPDH (linear). Relative observed DNA levels of HPV16 E2 and E6 are also presented at these time points. (C) Passage 1 UMSCC104s, obtained in 2024 from Millipore, were analyzed via the ExoV exonuclease assay. Percent integration was calculated as noted in panel B. (D) Passage 12 UMSCC104 cells were sequentially passaged in the presence or absence of J2. Western blotting for E2 was compared to E2 ± keratinocyte cell lines at the noted passage numbers. All experiments were conducted in biological and technical triplicate.

Fibroblast co-culture preserves episomal status of UMSCC104s

Fibroblast co-culture has been well established as a method to preserve episomal status of HPV+ epithelial cultures (10, 13). With that knowledge, we adapted this co-culture approach to determine if fibroblasts would also allow for the support and maintenance of the viral genome in UMSCC104s. Passage 12 UMSCC104 cells have a proportionate ratio of integrated and episomal genomes, as demonstrated in Fig. 1B. These cells were then grown in the presence or absence of J2s. As E2 expression is known to correlate with episomal status, E2 protein expression was monitored in UMSCC104 and compared to cells with known E2± status (Fig. 1D). UMSCC104s, grown in the traditional monoculture for four passages, had little-to-no detectable E2 protein expression (lane 3), when compared to HPV negative N/Tert-1 (lane 1) and episomal HPV16+ human foreskin keratinocytes (HFK+ HPV16, lane 2) consistently maintained on J2. Conversely, UMSCC104 cells maintained on J2 for eight passages had similar E2 protein expression levels as HFK+ HPV16 (lanes 5 and 6, respectively). At present, fibroblast coculture methods have demonstrated stable maintenance of episomal HPV16 genomes and E2 protein expression across >30 passages (not shown).

Fibroblasts support viral and host genome stability to reduce overall integration risks

We previously demonstrated that fibroblasts regulate the transcriptional signature of HPV+ keratinocytes (10). In our RNA sequencing (RNAseq) analysis, we observed that the removal of fibroblasts significantly reduced the gene expression of numerous DNA repair pathways (10). With that knowledge, we wanted to determine the effect of fibroblasts on DNA integrity in our various HPV+ models. N/Tert-1 cells (hTERT immortalized human foreskin keratinocytes), N/Tert-1 cells stably maintaining HPV16 episomal genomes (N/Tert-1 +HPV16), HFK+ HPV16 (foreskin keratinocytes immortalized by the entire HPV16 genome, replicating as an episome), and passage 14 UMSCC104s were grown in the presence or absence of J2s for 1 week (10, 20). The comet assay is a standard approach for measuring DNA strand breaks in single cells via electrophoresis (21). In the comet assay, intact supercoiled DNA remains within the dense “head” of the comet, whereas DNA fragments generated by strand breaks migrate and form a diffuse “tail” (21). The extent of DNA damage is then quantified by the olive tail moment, which is a measure of the tail length and the fraction of total DNA present in the tail (21). Fibroblast co-culture supported DNA integrity in all HPV+ cell lines, as observed by significantly smaller olive tail moments in Fig. 2A (for methodology, see reference 22).

Fig 2.

Microscopy data comparing DNA integrity with varying fibroblast presence. COMET assays show reduced DNA damage with fibroblasts. Fiber assays reveal continuous DNA replication with fibroblasts versus fragmented patterns without fibroblasts in HPV16 cells.

Fibroblasts enhance host genome stability, reducing the risk of viral integration. Noted cell lines were grown in the presence or absence of J2s for 1 week. UMSCC104 cells utilized were passage 14 from the Millipore lot obtained in 2015. (A) DNA strand breaks were assessed using the single-cell gel electrophoresis (COMET) assay. Cells were grown in 24 h, then trypsinized, washed, resuspended in 0.5% low molecular weight agarose, and subjected to single-cell gel electrophoresis. DNA was stained with SYBR Gold. Five randomly selected fields were imaged at 20× per replicate per cell line and conducted in biological and technical triplicate. The olive-tail moments (OTMs) of all nonoverlapping comets in each high-power field were quantified using CaspLabCOMET assay software. Average OTM ± SEM. (B) Cells were grown for 48 h and fiber assays were carried out in biological triplicate in indicated cell lines. A summary of “green” IdU fiber length is shown. The length of labeled tracks was measured using ImageJ software. A minimum of 100 individual fibers was analyzed for each experiment and each experiment was repeated two times. (C) Representative “aberrant” fibers observed in HFK+ HPV16 cells grown in the absence of J2 are shown in comparison to the representative “normal” fibers observed in these cells maintained in fibroblast co-culture. Similar aberrant fibers were observed in N/Tert-1 + HPV16 cells (not shown). *P < 0.05 and ***P < 0.001.

As the total level of observable DNA damage in a comet can be influenced by rates of repair, we also assessed replication fork dynamics utilizing the DNA fiber assay (23). Removal of fibroblasts resulted in significantly longer IdU fiber portions in all of our HPV+ keratinocytes, indicative of faster replication speeds (Fig. 2B; for methodology see reference 24). HPV+ keratinocytes grown in the absence of fibroblasts also had numerous instances of multiple replication origins per fiber and fork termination events, suggesting aberrant repair dynamics (representative images in Fig. 2C) (23). Future analysis will utilize HU labeling to further investigate fork stability, fork initiation, fork stalling, and fork degradation. Of note, despite repeated attempts, we were unable to CldU label UMSCC104 cells. We therefore refrain from drawing definitive conclusions about fork dynamics of these cells at this time. Overall, the combined increase in DNA damage (Fig. 2A) and altered replication dynamics (Fig. 2B) in the absence of fibroblasts would enhance opportunities for viral integration events.

DISCUSSION

Our findings demonstrate that conventional cancer cell line monoculture approaches do not support episomal maintenance in HPV+ HNSCC lines; without stromal support, viral integration and altered viral genome regulation occur in cell lines that were episomal when derived from patients. Episomal instability undermines the development of representative cell lines for studying HPV cancer biology and appropriate therapeutic responses. In contrast, fibroblast co-culture methods supported episomal stability in UMSCC104s, paralleling prior successes in HPV+ keratinocyte and CIN models. This strategy holds significant promise for generating more representative HPV+ OPC models. Episomal lines would better recapitulate the clinical presentation of HPV+ OPC. Of note, when UMSCC104s were retrieved from cryopreservation on fibroblasts, they had substantially improved recovery rates (not shown). We suggest that fibroblast co-culture may increase the overall success rate of establishing HPV+ lines from patient samples, a longstanding challenge in the field (9). While episomal cell lines are lacking, it is worth noting that episomal PDXs have been established (3). While episomal HPV16+ OPC cell lines are lacking, 50% of HPV16+ OPC PDXs retain episomes (3). The PDX episomal ratio much more closely reflects the ~70% episomal prevalence in patients (6–8). We further suggest that the more successful establishment and maintenance of episomal HPV16+ OPC PDXs may be supported by the adjacent mouse stroma.

Viral integration frequently occurs at “fragile sites”; these genomic regions are prone to replication stress and DNA breakage, which would create susceptible sites for integration events (13). If replication errors remain unresolved, chromosomal instability further increases opportunities for integration. We previously demonstrated that fibroblasts regulate both DNA repair pathways and numerous histones, in addition to the viral genome at the RNA level (10). We speculate that integration-associated stress and the absence of stromal cues in monoculture may similarly uncouple viral DNA abundance from RNA expression in UMSCC104 cells; this will be analyzed more in future studies. Here we further demonstrate that the presence of fibroblasts supported overall DNA integrity in our HPV+ models. Co-culture with fibroblasts decreased DNA strand breaks, at least in part by the regulation of replication fork dynamics (Fig. 2) and the expression of DNA damage repair factors (10).

Future studies will aim to develop patient-derived cell lines using this co-culture approach. This methodology has already proven effective for generating episomal cell lines from primary keratinocytes and CIN lesions, suggesting that a similar strategy could facilitate both the establishment and episomal maintenance of lines derived from cancerous lesions. Suggested fibroblast plating densities are further defined in the methods section. Establishing robust episomal HPV+ OPC models will provide a critical resource for advancing mechanistic insights and translational research.

MATERIALS AND METHODS

Cell culture

UMSCC104 (Millipore) and UMSCC152 (ATCC) cells were grown in Eagle’s minimum essential medium (Invitrogen) supplemented with nonessential amino acids (Gibco) and 20% fetal bovine serum (FBS) (Gibco) and were grown in the presence or absence of inactivated fibroblast feeder cells (described below). HN4 (generous gift from Dr. Hisashi Harada and FTR fingerprinted) and UMSCC47 (Millipore) cells were grown in were grown in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen, Carlsbad, CA, USA) supplemented with 10% FBS. N/Tert-1 and N/Tert-1 +HPV16 cells were maintained in keratinocyte-serum free medium (K-SFM; Invitrogen); +HPV16 cells were supplemented with 150 µg/mL G418 (Fisher Scientific). HFK+ HPV16 cells have been previously described and was grown in Dermalife-K complete media (Lifeline Technology) (18). All cells were maintained at 37°C in a 5% CO2 95% air atmosphere, passaged every 3 or 4 days, and routinely monitored for mycoplasma (Sigma, MP0035).

Culture and mitomycin C (MMC) inactivation of 3T3-J2 mouse fibroblast feeder cells

3T3-J2 immortalized mouse fibroblasts (J2) were grown in DMEM (Gibco) and supplemented with 10% FBS. 70–80% confluent plates were treated with 4 µg/mL of MMC in DMSO (Cell Signaling Technology) for 4–6 h at 37°C, as previously described (10). For co-culture conditions, every 2–3 days, 100 mm plates were supplemented with 1 × 106 J2, six-well plates were supplemented with 1 × 105 J2, or 24-well plates were supplemented with 1 × 104 J2. For long-term cultures, residual J2s were removed via short-term 0.05% Trypsin-EDTA (Gibco) exposure (<5 min), washed off with 1× PBS, and new J2 were continually supplemented every 2–3 days with fresh media supplementation.

Immunoblotting

Specified cells were washed with 1× PBS, trypsinized, lysed, and run as previously described (10). Membranes were blocked with Odyssey T-PBS blocking buffer at room temperature for at least 1 h and probed with the indicated primary antibody diluted in Odyssey blocking buffer. Membranes were washed with PBS supplemented with 0.1% Tween (PBS-Tween) and probed with the indicated Odyssey secondary antibody 1:10,000 (goat anti-mouse IRdye 800CW or goat anti-rabbit IRdye 680CW) diluted in Odyssey blocking buffer. Membranes were washed three times with PBS-Tween and an additional wash with 1× PBS. Infrared imaging of the blot was performed using the Odyssey CLx Li-Cor imaging system. The following primary antibodies were used for immunoblotting in this study at 1:500: E2 (25), GAPDH 1:1,000 (Santa Cruz, sc-47724).

Reproducibility, research integrity, and statistical analysis

All experiments were repeated at least three times and in biological triplicate in all of the cell lines indicated, unless otherwise indicated. All cell lines were bought directly from sources indicated, or typed via cell line authentication services. All images shown are representatives from triplicate experiments. Quantification is presented as mean ± standard error (SE). Student’s t-test was used to determine significance: *P < 0.05, **P < 0.01, and ***P < 0.001.

ACKNOWLEDGMENTS

This work was supported by the VCU Philips Institute for Oral Health Research, the OneVCU Research Quest Fund, and the National Cancer Institute-designated Massey Cancer Center (grant P30 CA016059).

Contributor Information

Molly L. Bristol, Email: mlbristol@vcu.edu.

Ira J. Blader, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA

REFERENCES

  • 1. Gribb JP, Wheelock JH, Park ES. 2023. Human Papilloma Virus (HPV) and the current state of oropharyngeal cancer prevention and treatment. Dela J Public Health 9:26–28. doi: 10.32481/djph.2023.04.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Malik S, Sah R, Muhammad K, Waheed Y. 2023. Tracking HPV infection, associated cancer development, and recent treatment efforts—a comprehensive review. Vaccines (Basel) 11:102. doi: 10.3390/vaccines11010102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. James CD, Otoa RO, Youssef AH, Fontan CT, Sannigrahi MK, Windle B, Basu D, Morgan IM. 2024. HPV16 genome structure analysis in oropharyngeal cancer PDXs identifies tumors with integrated and episomal genomes. Tumour Virus Res 18:200285. doi: 10.1016/j.tvr.2024.200285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Marur S, D’Souza G, Westra WH, Forastiere AA. 2010. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781–789. doi: 10.1016/S1470-2045(10)70017-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Tabatabaeian H, Bai Y, Huang R, Chaurasia A, Darido C. 2024. Navigating therapeutic strategies: HPV classification in head and neck cancer. Br J Cancer 131:220–230. doi: 10.1038/s41416-024-02655-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Nulton TJ, Kim N-K, DiNardo LJ, Morgan IM, Windle B. 2018. Patients with integrated HPV16 in head and neck cancer show poor survival. Oral Oncol 80:52–55. doi: 10.1016/j.oraloncology.2018.03.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Balaji H, Demers I, Wuerdemann N, Schrijnder J, Kremer B, Klussmann JP, Huebbers CU, Speel E-J. 2021. Causes and consequences of HPV integration in head and neck squamous cell carcinomas: state of the art. Cancers (Basel) 13:4089. doi: 10.3390/cancers13164089 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Koneva LA, Zhang Y, Virani S, Hall PB, McHugh JB, Chepeha DB, Wolf GT, Carey TE, Rozek LS, Sartor MA. 2018. HPV integration in HNSCC correlates with survival outcomes, immune response signatures, and candidate drivers. Mol Cancer Res 16:90–102. doi: 10.1158/1541-7786.MCR-17-0153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Le PN, Keysar SB, Miller B, Morton JJ, Chimed T-S, Alzofon N, Nieto C, Davies KD, Thomas CM, Weaver AN, Jimeno A. 2025. Improved methods for the stable generation of human papillomavirus-driven head and neck cancer cell lines. Mol Carcinog 64:1813–1822. doi: 10.1002/mc.70025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. James CD, Lewis RL, Witt AJ, Carter C, Rais NM, Wang X, Bristol ML. 2025. Fibroblasts regulate the transcriptional signature of human papillomavirus-positive keratinocytes. Tumour Virus Res 19:200302. doi: 10.1016/j.tvr.2024.200302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Brenner JC, Graham MP, Kumar B, Saunders LM, Kupfer R, Lyons RH, Bradford CR, Carey TE. 2010. Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck 32:417–426. doi: 10.1002/hed.21198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. White JS, Weissfeld JL, Ragin CCR, Rossie KM, Martin CL, Shuster M, Ishwad CS, Law JC, Myers EN, Johnson JT, Gollin SM. 2007. The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol 43:701–712. doi: 10.1016/j.oraloncology.2006.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Coursey TL, McBride AA. 2021. Development of keratinocyte cell lines containing extrachromosomal human papillomavirus genomes. Curr Protoc 1:e235. doi: 10.1002/cpz1.235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Spurgeon ME, Lambert PF. 2017. Human papillomavirus and the stroma: bidirectional crosstalk during the virus life cycle and carcinogenesis. Viruses 9:219. doi: 10.3390/v9080219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Jeon S, Allen-Hoffmann BL, Lambert PF. 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69:2989–2997. doi: 10.1128/JVI.69.5.2989-2997.1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Tang AL, Hauff SJ, Owen JH, Graham MP, Czerwinski MJ, Park JJ, Walline H, Papagerakis S, Stoerker J, McHugh JB, Chepeha DB, Bradford CR, Carey TE, Prince ME. 2012. UM-SCC-104: a new human papillomavirus-16–positive cancer stem cell–containing head and neck squamous cell carcinoma cell line. Head Neck 34:1480–1491. doi: 10.1002/hed.21962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Olthof NC, Huebbers CU, Kolligs J, Henfling M, Ramaekers FCS, Cornet I, van Lent-Albrechts JA, Stegmann APA, Silling S, Wieland U, Carey TE, Walline HM, Gollin SM, Hoffmann TK, de Winter J, Kremer B, Klussmann JP, Speel E-J. 2015. Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines. Int J Cancer 136:E207–E218. doi: 10.1002/ijc.29112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. James CD, Prabhakar AT, Otoa R, Evans MR, Wang X, Bristol ML, Zhang K, Li R, Morgan IM. 2019. SAMHD1 regulates human papillomavirus 16-induced cell proliferation and viral replication during differentiation of keratinocytes. mSphere 4:e00448-19. doi: 10.1128/mSphere.00448-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Myers JE, Zwolinska K, Sapp MJ, Scott RS. 2020. An exonuclease V–qPCR assay to analyze the state of the human papillomavirus 16 genome in cell lines and tissues. Curr Protoc Microbiol 59:e119. doi: 10.1002/cpmc.119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. James CD, Lewis RL, Fakunmoju AL, Witt AJ, Youssef AH, Wang X, Rais NM, Tadimari Prabhakar A, Machado JM, Otoa R, Bristol ML. 2024. Fibroblast stromal support model for predicting human papillomavirus-associated cancer drug responses. bioRxiv:2024.04.09.588680. doi: 10.1101/2024.04.09.588680 [DOI] [PMC free article] [PubMed]
  • 21. Collins AR. 2004. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 26:249–261. doi: 10.1385/MB:26:3:249 [DOI] [PubMed] [Google Scholar]
  • 22. Fontan CT, James CD, Prabhakar AT, Bristol ML, Otoa R, Wang X, Karimi E, Rajagopalan P, Basu D, Morgan IM. 2022. A critical role for p53 during the HPV16 life cycle. Microbiol Spectr 10:e00681-22. doi: 10.1128/spectrum.00681-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Halliwell JA, Gravells P, Bryant HE. 2020. DNA fiber assay for the analysis of DNA replication progression in human pluripotent stem cells. Curr Protoc Stem Cell Biol 54:e115. doi: 10.1002/cpsc.115 [DOI] [PubMed] [Google Scholar]
  • 24. James CD, Youssef AH, Roe JD, Cappiello F, Aiello FA, Perdichizzi B, Lewis RL, Witt A, Prabhakar AT, Wang X, Bristol ML, Pichierri P, Morgan IM. 2025. HPV16 recruitment of SMARCAL1 to viral and host replication forks is required for the viral life cycle. bioRxiv:2025.07.22.666081. doi: 10.1101/2025.07.22.666081 [DOI] [PMC free article] [PubMed]
  • 25. Wieland A, Patel MR, Cardenas MA, Eberhardt CS, Hudson WH, Obeng RC, Griffith CC, Wang X, Chen ZG, Kissick HT, Saba NF, Ahmed R. 2021. Defining HPV-specific B cell responses in patients with head and neck cancer. Nature 597:274–278. doi: 10.1038/s41586-020-2931-3 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from mSphere are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES